Protein drugs have become a critical part of healthcare. They attack diseases differently than old fashioned small molecule drugs, and have helped the biotech industry rise to prominence over the past few decades.
But proteins have their limitations. Many have to be taken frequently, or infused in hospitals, to work the way they should. Lessening that burden could provide a big convenience to patients, something a startup called Arsia Therapeutics is trying help out with.
Volkswagen ha obtenido un crédito puente de 20.000 millones con trece bancos. Santander y BBVA meten 1.080 millones cada uno.
Santander y BBVA quieren echarle una mano a Volkswagen. La compañía alemana firmó el pasado 4 de diciembre un crédito multimillonario de 20.000 millones de euros con trece bancos a un plazo de doce meses. Se trata de un préstamo puente hasta que logre recuperar la confianza de los inversores y pueda realizar de nuevo emisiones de bonos en los mercados internacionales. Así podrá ir cubriendo las multas y las compensaciones multimillonarias a las que se enfrenta la compañía por el escándalo de las emisiones de sus motores diesel.
All venture capitalists like to say they invest in companies looking to disrupt big markets — that next unicorn. And every startup pitch deck will showcase huge numbers on their market size slide, prompting more than a few sideways glances in the room. (We’ve tried to address some of those issues in our recent pitch deck templates.)
With 2014 breaking all records for digital health funding, we entered 2015 wondering if the pace would continue. We shouldn’t have been doubtful—digital health funding in 2015 matched the total of 2014, surpassing $4.3B in funding. While skeptics may use the flatness of growth to question the attractiveness of the digital health industry, it’s important to keep in perspective what an incredible feat it was for 2015 to be on track with record-breaking 2014.
Funding to education-technology companies is booming. Overall, the period from 2010 to 2014 saw more than a 503% growth in investment dollars.
The pace has held high even in recent quarters. Financing grew from $911M in 2013 to over $1.5B in 2014, a 71% increase year-over-year. In the last four quarters, including Q2’15, ed tech startups attracted $1.9B, a jump of 68% compared to the previous four quarters.
Meanwhile, deal count has carried along steadily. There were 193 deals in 2014, up from 176 in 2013. However, at the current run rate 2015 will see a deal count of 158, well below that of previous years which indicates that deals are becoming fewer yet larger. Note: This data only includes funding to VC-backed companies in the Ed Tech space.
ULMA Architectural Solutionsek Zaragozako Caixaforum kultur etxe berriaren proiektuan hartu du parte, drainatze kanalen gama zabalaren instalazioarekin.
Kultur etxe hori La Caixa Fundazioaren zati da eta Anselmo Clavé 4 Etorbidean dago, tren geltokiaren ondoan. Lurzatiak 4.407 metro karratuko eremua hartzen du bere baitan. Publiko guztiei begirako obra da eta hainbat kultur jarduera eskaintzen ditu, hala nola, hitzaldiak, mintegiak, zinema, musika eta antzerkia.
En el año 2015 FAGOR ARRASATE, fiel a su compromiso de compartir los retos de sus clientes "SHARING YOUR CHALLENGES”, pondrá en marcha una nueva servo-blanking-line para un importante OEM en India. Esta instalación permitirá al fabricante atender el anteriormente mencionado aumento de la producción.
SORALUCE, A&B Laboratorios, TKNIKA, Vicomtech, Colegio Urkide Ikastetxea eta Osakidetza izan dira Euskadin 2015eko Quality Innovation of the Year saria irabazi dutenak. Enpresa hauek gainera Europako 2015eko Quality Innovation of the Year sariketan finalista ere aurkeztuko dira 2016ko urtarrilean Tallinnen (Estonia) aukeratuko delarik irabazlea. Lehiaketa Finlandian sortu zen 2007an produktuen, prozesuen, erakundeen eta bestelakoen arloan berrikuntzaren sorrera eta garapena sustatzeko helburuarekin.
SORALUCE, A&B Laboratorios, TKNIKA, Vicomtech, Colegio Urkide Ikastetxea y Osakidetza son los ganadores del Quality Innovation of the year 2015 en Euskadi. Estas empresas además se presentan como finalistas al premio Europeo Quality Innovation of the Year 2015 que se decidirá en Tallinn (Estonia) en Enero 2016.
Ebakuntza kirurgiko bat planifikatu ahal izatea funtsezkoa da arriskuak ahalik eta gehien murrizteko. Gainera, azken teknologiei esker medikuek pazientearen aurretiko bioeredu bat izan dezakete –haren bizkarrezurrarena nahiz gorputzeko beste atal batena–, ebakuntza planifikatzeko.
